Showing results (41-50 of 67) with videos related to

Sort By:
Pageof 7
Scandinavian Journal of Gastroenterology|April 24, 2012
Fecal calprotectin and S100A12 have low utility in prediction of small bowel Crohn's disease detected by wireless capsule endoscopyTaina Sipponen, Johanna Haapamäki, Erkki Savilahti, et al.
Plos One|August 17, 2013
Dendritic cells from Crohn's disease patients show aberrant STAT1 and STAT3 signalingJanne K Nieminen, Mirja Niemi, Taina Sipponen, et al.
Journal of Pediatric Gastroenterology and Nutrition|April 21, 2017
Detailed Follow-up Study of Pediatric Orofacial Granulomatosis PatientsAnu Haaramo, Heikki Alapulli, Liisa Aine, et al.
Inflammatory Bowel Diseases|January 7, 2012
Fecal calprotectin concentration predicts outcome in inflammatory bowel disease after induction therapy with TNFα blocking agentsPauliina Molander, Clas-Göran af Björkesten, Harri Mustonen, et al.
Journal of Crohn'S & Colitis|December 10, 2020
Bacterial and Fungal Profiles as Markers of Infliximab Drug Response in Inflammatory Bowel DiseaseRebecka Ventin-Holmberg, Anja Eberl, Schahzad Saqib, et al.
Gastroenterology|September 11, 2012
Segregation of a missense variant in enteric smooth muscle actin γ-2 with autosomal dominant familial visceral myopathyHeli J Lehtonen, Taina Sipponen, Sari Tojkander, et al.
ISRN Gastroenterology|July 11, 2012
In Crohn's Disease, Anti-TNF-α Treatment Changes the Balance between Mucosal IL-17, FOXP3, and CD4 CellsVeera Hölttä, Taina Sipponen, Mia Westerholm-Ormio, et al.
Journal of Crohn'S & Colitis|November 28, 2012
Achievement of deep remission during scheduled maintenance therapy with TNFα-blocking agents in IBDPauliina Molander, Taina Sipponen, Helena Kemppainen, et al.
Inflammatory Bowel Diseases|May 31, 2008
IL-23/IL-17 immunity as a hallmark of Crohn's diseaseVeera Hölttä, Paula Klemetti, Taina Sipponen, et al.
Pageof 7